4.3 Review

A systematic review, pairwise meta-analysis and network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in irritable bowel syndrome

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial

Tom Holvoet et al.

Summary: Fecal microbiota transplantation (FMT) therapy has shown promising efficacy in treating patients with treatment-resistant Irritable Bowel Syndrome (IBS), particularly in relieving predominant bloating symptoms. The treatment response was associated with higher microbiome diversity in stool samples before FMT administration, suggesting a potential biomarker for patient selection.

GASTROENTEROLOGY (2021)

Letter Gastroenterology & Hepatology

FMT in IBS: how cautious should we be?

Magdy El-Salhy

Article Gastroenterology & Hepatology

Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome

Magdy El-Salhy et al.

Summary: This study found that FMT can increase the fecal SCFA levels in IBS patients. The increase in butyric acid is negatively correlated with symptoms in IBS patients, suggesting that SCFAs may play a role in the pathophysiology of IBS.

NEUROGASTROENTEROLOGY AND MOTILITY (2021)

Article Gastroenterology & Hepatology

Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis

Theodore Rokkas et al.

Summary: The study compared the effectiveness of different first-line regimens for Helicobacter pylori infection through a network meta-analysis. Results showed that vonoprazan triple therapy and reverse hybrid therapy achieved high eradication rates above 90%, with levofloxacin triple therapy performing best in Western countries. Standard triple therapy was found to be the least efficacious in this analysis.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome

Magdy El-Salhy et al.

Summary: The study found no significant sex difference in the response to FMT among IBS patients, but for female patients with diarrhea-predominant symptoms, the efficacy of FMT is more pronounced.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century

Magdy El-Salhy et al.

Summary: Irritable bowel syndrome (IBS) affects about 12% of the global population, with the etiology still unclear but intestinal microbiota playing a pivotal role in its pathophysiology. Fecal microbiota transplantation (FMT) has shown positive effects in some randomized controlled trials (RCTs), but further research is needed to determine the optimal treatment approach.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Letter Gastroenterology & Hepatology

Letter: faecal microbiota transplantation for IBS

Jonathan P. Segal et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Letter Gastroenterology & Hepatology

Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement

Gianluca Ianiro et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Review Biochemistry & Molecular Biology

Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome

Yoshiyuki Mishima et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

Clostridium ramosum regulates enterochromaffin cell development and serotonin release

Ana D. Mandic et al.

SCIENTIFIC REPORTS (2019)

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome

Gianluca Ianiro et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Article Gastroenterology & Hepatology

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

Olga C. Aroniadis et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Medicine, General & Internal

Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant

Zachariah DeFilipp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Editorial Material Medicine, General & Internal

Fecal Microbiota Transplantation for Dysbiosis - Predictable Risks

Martin J. Blaser

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Gastroenterology & Hepatology

Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis

Dabo Xu et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

Review Gastroenterology & Hepatology

Fecal microbiota transplantation for managing irritable bowel syndrome

Magdy El-Salhy et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2018)

Review Gastroenterology & Hepatology

Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis

Gianluca Ianiro et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)

Review Gastroenterology & Hepatology

Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease

Magdy El-Salhy et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

Review Gastroenterology & Hepatology

What Is New in Rome IV

Max J. Schmulson et al.

JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2017)

Review Gastroenterology & Hepatology

Irritable bowel syndrome: a gut microbiota-related disorder?

Yogesh Bhattarai et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)

Article Gastroenterology & Hepatology

Bowel Disorders

Brian E. Lacy et al.

GASTROENTEROLOGY (2016)

Review Gastroenterology & Hepatology

Pathophysiology of irritable bowel syndrome

Gerald J. Holtmann et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)

Article Biochemistry & Molecular Biology

Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis

Jessica M. Yano et al.

Article Gastroenterology & Hepatology

Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States

Anne F. Peery et al.

GASTROENTEROLOGY (2015)

Review Medicine, General & Internal

Irritable Bowel Syndrome A Clinical Review

William D. Chey et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Article Gastroenterology & Hepatology

Recent developments in the pathophysiology of irritable bowel syndrome

Magdy El-Salhy

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Article Gastroenterology & Hepatology

The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis

T. Rokkas et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2015)

Article Gastroenterology & Hepatology

Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria

A. C. Ford et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)

Article Multidisciplinary Sciences

Evaluating the Quality of Evidence from a Network Meta-Analysis

Georgia Salanti et al.

PLOS ONE (2014)

Article Multidisciplinary Sciences

Graphical Tools for Network Meta-Analysis in STATA

Anna Chaimani et al.

PLOS ONE (2013)

Review Endocrinology & Metabolism

5-Hydroxytryptamine (serotonin) in the gastrointestinal tract

Michael D. Gershon

CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2013)

Review Gastroenterology & Hepatology

Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis

Rebecca M. Lovell et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

I. M. Carroll et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2012)

Article Gastroenterology & Hepatology

Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome

Ian M. Carroll et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)

Article Health Care Sciences & Services

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

Georgia Salanti et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Review Immunology

Gut hormones: emerging role in immune activation and inflammation

W. I. Khan et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)

Review Gastroenterology & Hepatology

The serotonin signaling system: From basic understanding to drug development-for functional GI disorders

Michael D. Gershon et al.

GASTROENTEROLOGY (2007)

Review Gastroenterology & Hepatology

Systematic review - natural history of irritable bowel syndrome

HB El-Serag et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)

Article Gastroenterology & Hepatology

The impact of irritable bowel syndrome on health-related quality of life

IM Gralnek et al.

GASTROENTEROLOGY (2000)